As of October 4, 2026, Anthropic’s IPO was planned, not launched. It had announced a confidential draft S-1 submission on June 1, but had not published a prospectus or confirmed a listing date, share price or amount to be raised. Reports of a leaked draft give investors an early view of the business—not final offering terms.
15
6
3
- The timetable has slipped. An anticipated post–Labor Day prospectus and early-autumn listing did not materialize. Reuters subsequently reported marketing no earlier than mid-October; newer Bloomberg reports pointed to an October 14 meeting for selected investors and a possible November debut. Those are reported plans, not firm dates.
6
1
13
12
- A public filing is still required. Confidential SEC review does not replace a public registration statement. Under the SEC’s confidential-submission rules, the initial draft and amendments must be made public at least 15 days before the roadshow; a private investor meeting should not be mistaken for the start of a public offering.
1
2
- The scale is enticing but unpriced. Reports discuss a valuation around or above $2 trillion, potentially making this a historic IPO. That is a prospective valuation, not proceeds to Anthropic: without a public share count and price range, the amount it would raise remains unknown.
4
10
3
- The leaked numbers make the investment case difficult. Reuters reported roughly $4.6 billion in 2025 revenue—about twelvefold growth—but an operating loss exceeding $8 billion and a $42 billion net loss. The draft also described at least $518 billion of computing and infrastructure commitments over roughly a decade, while reporting highlighted that 47% of sales flowed through a concentrated set of relationships. These figures come from a draft seen by reporters, not an investor-verifiable public prospectus.
7
6
4
- Risks could affect price or timing. The draft’s warnings about potentially catastrophic or existential AI risks add to questions about safety, customer dependence and how the infrastructure buildout will be financed. Strong growth could attract buyers, but a cooler U.S. IPO market and the size of the proposed valuation leave open a lower price, another delay or no near-term offering. There is insufficient evidence to predict which outcome investors will accept.
7
4
11